2012
DOI: 10.1111/j.1365-2133.2011.10663.x
|View full text |Cite
|
Sign up to set email alerts
|

Low-dose rituximab is effective in pemphigus

Abstract: A low dose of rituximab is an effective and safe treatment for pemphigus. Relapses may occur, mostly at the end of the second year. Cost-effectiveness studies with a long follow-up are required to determine the proper dosage of this expensive drug in pemphigus.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
77
1
5

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 94 publications
(91 citation statements)
references
References 39 publications
8
77
1
5
Order By: Relevance
“…38 Lower doses of rituximab are less effective 39,40 • Rituximab can be combined with short-term (<4 months old) systemic corticosteroids and long-term (>12 months old) immunosuppressive treatment…”
Section: Immunoadsorptionmentioning
confidence: 99%
“…38 Lower doses of rituximab are less effective 39,40 • Rituximab can be combined with short-term (<4 months old) systemic corticosteroids and long-term (>12 months old) immunosuppressive treatment…”
Section: Immunoadsorptionmentioning
confidence: 99%
“…A recent prospective open case series reported that a low dose rituximab regimen consisting of two 500 mg infusions separated by two weeks was effective in pemphigus. This is just 39% of the hematological dose and yet more than 73% of the patients achieved complete remission [6].…”
Section: Discussionmentioning
confidence: 99%
“…Both lymphoma regimen (four, weekly infusions of 375 mg/m 2 ) and rheumatologic dose (two infusions of one gram each separated by two weeks) have been successfully used to treat autoimmune blistering diseases including pemphigus [5]. Studies have shown that antibody producing B cells in the Pemphigus are not malignant and a single dose as low as 100 mg/m 2 can deplete B cells [6]. A recent prospective open case series reported that a low dose rituximab regimen consisting of two 500 mg infusions separated by two weeks was effective in pemphigus.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Düşük doz rituksimabın da etkili ve güvenli olabileceğini düşünmüşlerdir. Bu tedavi yönteminde relapsların özellikle tedavi sonrası 2. yıl sonunda gözlendiğini belirtmişlerdir (88). Matsukura ve ark ise tek doz şeklinde 1 ve 15. günlerde rituksimab tedavisinin diğer tedavilerle kombine edilmesinin pemfiguslu 9 hastada etkili olduğunu göstermişler-dir (87).…”
Section: B-otoimmun Büllöz Hastalıklar 1-pemfigus Vulgarisunclassified